Drug Pipeline

Pimavanserin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
4
Recruiting
5
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-27 NCT07610135 Psilocybin Efficacy With or Without Pimavanserin Pretreatment Phase 1/2 Not Yet Recruiting
Active Studies by Phase
Phase 2
3
Phase 1/2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05999240 Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder Autism Spectrum Disorder Recruiting
NCT05441280 Pimavanserin for Insomnia in Veterans With PTSD Post-traumatic Stress Disorder Recruiting
NCT06455293 Psilocybin Therapy for Depression in Parkinson's Disease Parkinson Disease Recruiting
Phase 1/2
NCT07610135 Psilocybin Efficacy With or Without Pimavanserin Pretreatment Mood (Psychological Function) Not Yet Recruiting
Not specified
NCT07022366 Investigating the Neuropsychological Effects of 5-HT2a Antagonism Healthy Recruiting
Sponsors Running Pimavanserin Trials
VA Office of Research and Development (1) New York State Psychiatric Institute (1) Joshua Woolley, MD, PhD (1) University of Oxford (1) Johns Hopkins University (1)
Disease Areas
PTSD (1) Parkinson's Disease (1) Depression (1)
Get alerts when Pimavanserin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free